Q4 2025 Holdings
Filed 2026-02-17 | 20 holdings | $544.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $87.5M | 649,179 | 16.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $54.3M | 4,496,487 | 10.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $43.2M | 1,217,064 | 7.9% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $42.2M | 248,070 | 7.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $36.9M | 798,940 | 6.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $35.0M | 1,788,616 | 6.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $31.6M | 1,140,033 | 5.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $31.6M | 317,095 | 5.8% |
| Alumis Inc(ALMS) | COM | 022307102 | $30.6M | 3,135,953 | 5.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $23.7M | 298,429 | 4.3% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $23.2M | 5,800,530 | 4.3% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $21.3M | 325,701 | 3.9% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $19.1M | 7,735,386 | 3.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $18.3M | 1,504,880 | 3.4% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $15.7M | 2,999,169 | 2.9% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $10.3M | 516,761 | 1.9% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $7.9M | 3,856,799 | 1.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $7.1M | 282,692 | 1.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $4.1M | 2,500,000 | 0.7% |
| Inventiva SA(IVA) | ADS | 46124U107 | $1.3M | 283,166 | 0.2% |